发文分析
近年国家/地区发文量统计
| 国家/地区 | 数量 |
|---|---|
| USA | 2085 |
| England | 1726 |
| Spain | 1493 |
| Italy | 1373 |
| Netherlands | 1192 |
| GERMANY (FED REP GER) | 1174 |
| France | 1100 |
| Japan | 773 |
| CHINA MAINLAND | 709 |
| Turkey | 675 |
近年机构发文量统计
| 机构 | 数量 |
|---|---|
| ASSISTANCE PUBLIQUE HOPITAUX PARIS (APHP) | 562 |
| FREE UNIVERSITY OF BERLIN | 360 |
| HUMBOLDT UNIVERSITY OF BERLIN | 358 |
| LEIDEN UNIVERSITY | 348 |
| UNIVERSITY OF LONDON | 347 |
| INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERC... | 297 |
| UNIVERSITY OF LEEDS | 294 |
| KAROLINSKA INSTITUTET | 277 |
| HARVARD UNIVERSITY | 275 |
| UNIVERSITE DE PARIS | 253 |
近年文章引用他刊数据
| 文章名称 | 引用次数 |
|---|---|
| 2019 update of the EULAR recommendations for the managem... | 200 |
| EULAR recommendations for the use of imaging in large ve... | 118 |
| EULAR recommendations for the management of antiphosphol... | 109 |
| 2019 European League Against Rheumatism/American College... | 98 |
| 2018 update of the EULAR recommendations for the managem... | 96 |
| 2018 EULAR recommendations for physical activity in peop... | 80 |
| Circular RNA VMA21 protects against intervertebral disc ... | 54 |
| Safety and efficacy of subcutaneous tocilizumab in syste... | 51 |
| Efficacy and safety of tocilizumab in patients with refr... | 51 |
| Risankizumab, an IL-23 inhibitor, for ankylosing spondyl... | 51 |
近年被他刊引用数据
| 期刊名称 | 引用次数 |
|---|---|
| ANN RHEUM DIS | 2188 |
| RHEUMATOLOGY | 1480 |
| ARTHRITIS RES THER | 1154 |
| CLIN RHEUMATOL | 1122 |
| FRONT IMMUNOL | 1070 |
| CLIN EXP RHEUMATOL | 914 |
| ARTHRITIS RHEUMATOL | 909 |
| INT J RHEUM DIS | 738 |
| J RHEUMATOL | 661 |
| RHEUMATOL INT | 648 |